The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · cited 1×
“Chronic stress paradigms An alternative model for inducing depression-like behaviours tilises chronic, mild, and unpredictable stressors over a period of ime (Willner et al., 1987).”
BackgroundInternational Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375 · cited 2×
“In this area the emerging technologies of induced pluripotent stem cells (iPS) derived from peripheral somatic cells of patients with these psychiatric disorders may provide a viable alternative source of human CNS cell lines (Brennand et al., 2011).”
BackgroundImitola, J., Raddassi, K., Park, K. I., Mueller, F.-J., Nieto, M., Teng, Y. D., Frenkel, D., Li, J., Sidman, R. L., Walsh, C. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408258102 · Cited by 1,057
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Kapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Evidence for a cytokine model of cognitive function
McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760
Self-citationInflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., & Miller, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14500 · Cited by 692
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., Weeber, E. J., Bickford, P. C., & Gemma, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-11.2011 · Cited by 624
Fillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Lindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., Hansson, O., Björkqvist, M., Träskman-Bendz, L., & Brundin, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.030 · Cited by 524 · cited 1×
“Similarly, another study found no ssociations between serum or CSF CXCL8 and suicide attempts ompared to matched healthy controls without psychiatric disrder (Lindqvist et al., 2009), however the same investigators ater detected a significant reduction in CSF CXCL8 in patients ith depression who attempted suicide as c…”
ResultIs depression an inflammatory disorder?
Raison, C. L., & Miller, A. H. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0232-0 · Cited by 524 · cited 1×
“This is likely related to the hypotheses of an inflammatory pathogenesis of each of these disorders that have been favoured in the last decade (Goldstein et al., 2009; Krstic and Knuesel, 2013; Meyer, 2011; Raison and Miller, 2011).”
BackgroundCan neuroscience be integrated into the DSM-V?
Hyman, S. E. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2218 · Cited by 516
Shelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Goldstein, B. I., Kemp, D. E., Soczynska, J. K., & McIntyre, R. S. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04505 · Cited by 510
Elevated Maternal Interleukin-8 Levels and Risk of Schizophrenia in Adult Offspring
Brown, A. S., Hooton, J., Schaefer, C. A., Zhang, H., Petkova, E., Babulas, V., Perrin, M., Gorman, J. M., & Susser, E. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.889 · Cited by 489
Deciphering the mechanism underlying late-onset Alzheimer disease
Krstic, D., & Knuesel, I. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.236 · Cited by 457
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453
Emerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381
The role of cognitive impairment in general functioning in major depression
Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · cited 1×
“It is however important to note that cognitive impairment is also a challenging to treat component of many other psychiatric and neurological disorders and may contribute greatly to the morbidity associated with those disorders, for example depression and multiple sclerosis (Baune et al., 2010; He et al., 2013).”
BackgroundSelf-citationO’Brien, S. M., Scully, P., Fitzgerald, P., Scott, L. V., & Dinan, T. G. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.013 · Cited by 355
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Depression and immunity: A role for T cells?
Miller, A. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.009 · Cited by 337
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Maternal Cytokine Levels during Pregnancy and Adult Psychosis
Buka, S. L., Tsuang, M. T., Torrey, E. F., Klebanoff, M. A., Wagner, R. L., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0644 · Cited by 321
Chemokines: a new class of neuromodulator?
Rostène, W., Kitabgi, P., & Parsadaniantz, S. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2255 · Cited by 320
Neuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319
Self-citationPro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
The Role of Immune System in Schizophrenia
Muller, N., & J. Schwarz, M. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823673 · Cited by 291
Warner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease
Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289
A detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286 · cited 4×
“Several small (n = 9 and n = 59, respectively) crossectional studies which defined depression according to DSM-IV riteria found that serum CCL3 was increased in the serum of atients with depression compared to controls (Merendino et al., 004; Simon et al., 2008).”
BackgroundInfluentialCytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
The expression and function of chemokines involved in CNS inflammation
Ubogu, E. E., Cossoy, M. B., & Ransohoff, R. M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.002 · Cited by 278
Westin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277
Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity
Stuart, M. J., & Baune, B. T. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.001 · Cited by 257
Self-citationBradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
Sokolova, A., Hill, M. D., Rahimi, F., Warden, L. A., Halliday, G. M., & Shepherd, C. E. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00188.x · Cited by 249
Pro-cognitive properties of T cells
Kipnis, J., Gadani, S., & Derecki, N. C. (2012) · Nature Reviews Immunology · doi:10.1038/nri3280 · Cited by 246
Microglia Modulate Hippocampal Neural Precursor Activity in Response to Exercise and Aging
Vukovic, J., Colditz, M. J., Blackmore, D. G., Ruitenberg, M. J., & Bartlett, P. F. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5925-11.2012 · Cited by 241
Current status of chemokines in the adult CNS
Réaux-Le Goazigo, A., Van Steenwinckel, J., Rostène, W., & Mélik Parsadaniantz, S. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.001 · Cited by 236
Song, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Whelan, A., Cosyns, P., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00025-1 · Cited by 232
Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain
Tran, P. B., Banisadr, G., Ren, D., Chenn, A., & Miller, R. J. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21229 · Cited by 231
Regulation of chemokine receptor expression in human microglia and astrocytes
Flynn, G., Maru, S., Loughlin, J., Romero, I. A., & Male, D. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00009-2 · Cited by 229
Ellman, L. M., Deicken, R. F., Vinogradov, S., Kremen, W. S., Poole, J. H., Kern, D. M., Tsai, W. Y., Schaefer, C. A., & Brown, A. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.014 · Cited by 225
Identification of a biological signature for schizophrenia in serum
Schwarz, E., Guest, P. C., Rahmoune, H., Harris, L. W., Wang, L., Leweke, F. M., Rothermundt, M., Bogerts, B., Koethe, D., Kranaster, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.42 · Cited by 222
Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
Soares, H. D. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1070 · Cited by 218
Serum and gene expression profile of cytokines in first-episode psychosis
Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.010 · Cited by 217
Identification of differentially expressed microRNAs across the developing human brain
Ziats, M. N., & Rennert, O. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.93 · Cited by 214
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease
Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209
Platelet Reactivity in Depressed Patients Treated With Paroxetine: Preliminary Findings
Musselman, D. L., Marzec, U. M., Manatunga, A., Penna, S., Reemsnyder, A., Knight, B. T., Baron, A., Hanson, S. R., & Nemeroff, C. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.875 · Cited by 205
Corona, A. W., Huang, Y., O'Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., & Godbout, J. P. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-93 · Cited by 200
Suarez, E. C., Krishnan, R. R., & Lewis, J. G. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000035719.79068.2b · Cited by 199
Glucocorticoid hormones and early brain development in schizophrenia
Ph.D., J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00396-7 · Cited by 199
Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
Hu, W. T., Chen-Plotkin, A., Arnold, S. E., Grossman, M., Clark, C. M., Shaw, L. M., Pickering, E., Kuhn, M., Chen, Y., McCluskey, L., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0667-0 · Cited by 198
Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Cao, L. Y., & Shen, Y. C. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00296-1 · Cited by 198
CCL2/MCP-1 modulation of microglial activation and proliferation
Hinojosa, A. E., Garcia-Bueno, B., Leza, J. C., & Madrigal, J. L. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-77 · Cited by 197
Banisadr, G., Fontanges, P., Haour, F., Kitabgi, P., Rostène, W., & Mélik Parsadaniantz, S. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02237.x · Cited by 197
The role of BDNF in the pathophysiology and treatment of schizophrenia
Favalli, G., Li, J., Belmonte-de-Abreu, P., Wong, A. H. C., & Daskalakis, Z. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.022 · Cited by 196
CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis
Omari, K. M., John, G. R., Sealfon, S. C., & Raine, C. S. (2005) · Brain · doi:10.1093/brain/awh479 · Cited by 196
MCP-1 induces migration of adult neural stem cells
Widera, D., Holtkamp, W., Entschladen, F., Niggemann, B., Zänker, K., Kaltschmidt, B., & Kaltschmidt, C. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00403 · Cited by 194
Molecular mechanisms of neuropathological changes in Alzheimer’s disease: a review
Šerý, O., Povová, J., Míšek, I., Pešák, L., & Janout, V. (2013) · Folia Neuropathologica · doi:10.5114/fn.2013.34190 · Cited by 190
Rodent models in depression research: Classical strategies and new directions
Pollak, D. D., Rey, C. E., & Monje, F. J. (2010) · Annals of Medicine · doi:10.3109/07853891003769957 · Cited by 187
Alzheimer's Disease: A General Introduction and Pathomechanism
Finder, V. H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100975 · Cited by 185
Suarez, E. C., Lewis, J. G., Krishnan, R. R., & Young, K. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.01.002 · Cited by 185
The pipeline and future of drug development in schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002062 · Cited by 184
Baune, B. T., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P., & Trollor, J. N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.006 · Cited by 184
Self-citationNeuroplasticity signaling pathways linked to the pathophysiology of schizophrenia
Balu, D. T., & Coyle, J. T. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.005 · Cited by 181
Sun, Y.-X., Minthon, L., Wallmark, A., Warkentin, S., Blennow, K., & Janciauskiene, S. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000071001 · Cited by 180
Banisadr, G., Quéraud‐Lesaux, F., Boutterin, M. C., Pélaprat, D., Zalc, B., Rostène, W., Haour, F., & Mélik Parsadaniantz, S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00809.x · Cited by 177
Baune, B. T., Stuart, M. J., Gilmour, A., Wersching, H., Heindel, W. L., Arolt, V., & Berger, K. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.18 · Cited by 177
Self-citationCroitoru‐Lamoury, J., Guillemin, G. J., Boussin, F. D., Mognetti, B., Gigout, L. I., Chéret, A., Vaslin, B., Le Grand, R., Brew, B. J., & Dormont, D. (2003) · Glia · doi:10.1002/glia.10181 · Cited by 177
The activation of monocyte and T cell networks in patients with bipolar disorder
Drexhage, R. C., Hoogenboezem, T. H., Versnel, M. A., Berghout, A., Nolen, W. A., & Drexhage, H. A. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.013 · Cited by 173
Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes
Guillemin, G. J., Croitoru‐Lamoury, J., Dormont, D., Armati, P. J., & Brew, B. J. (2003) · Glia · doi:10.1002/glia.10175 · Cited by 173
Multisite Comparison of High-Sensitivity Multiplex Cytokine Assays
Breen, E. C., Reynolds, S. M., Cox, C., Jacobson, L. P., Magpantay, L., Mulder, C. B., Dibben, O., Margolick, J. B., Bream, J. H., Sambrano, E., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05032-11 · Cited by 172
Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170
Corona, A. W., Norden, D. M., Skendelas, J. P., Huang, Y., O’Connor, J. C., Lawson, M. A., Dantzer, R., Kelley, K. W., & Godbout, J. P. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.008 · Cited by 166
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
Stephan, B. C. M., Minett, T., Pagett, E., Siervo, M., Brayne, C., & McKeith, I. G. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-001909 · Cited by 164
Rathbun, A. M., Reed, G. W., & Harrold, L. R. (2012) · Rheumatology · doi:10.1093/rheumatology/kes356 · Cited by 163
Chemokines and neuromodulation
Mélik-Parsadaniantz, S., & Rostène, W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.022 · Cited by 162
RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role
Tripathy, D., Thirumangalakudi, L., & Grammas, P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.009 · Cited by 161
Beumer, W., Drexhage, R. C., De Wit, H., Versnel, M. A., Drexhage, H. A., & Cohen, D. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.001 · Cited by 161
Chemokines in CNS injury and repair
Järve, A., & Müller, H. W. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1427-3 · Cited by 160
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
Piletz, J. E., Halaris, A. E., Iqbal, O., Hoppensteadt, D., Fareed, J., Zhu, H., Sinacore, J. M., & DeVane, C. L. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802573246 · Cited by 157
Increased production of inflammatory cytokines in mild cognitive impairment
Magaki, S., Mueller, C., DICKSON, C., & Kirsch, W. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.015 · Cited by 157
Nakatani, N., Hattori, E., Ohnishi, T., Dean, B., Iwayama, Y., Matsumoto, I., Kato, T., Osumi, N., Higuchi, T., Niwa, S., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl118 · Cited by 155
Ragozzino, D., Angelantonio, S. D., Trettel, F., Bertollini, C., Maggi, L., Gross, C. T., Charo, I. F., Limatola, C., & Eusebi, F. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3192-06.2006 · Cited by 153
Rostène, W. H., Dansereau, M., Godefroy, D., Steenwinckel, J. V., Goazigo, A. R.-L., Parsadaniantz, S. M., Apartis, E., Hunot, S., Beaudet, N., & Sarret, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07371.x · Cited by 149
Giovannelli, A., Limatola, C., Ragozzino, D., Mileo, A. M., Ruggieri, A., Ciotti, M. T., Mercanti, D., Santoni, A., & Eusebi, F. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00192-1 · Cited by 148
Systemic immune aberrations in Alzheimer's disease patients
Bonotis, K. S., Krikki, E., Holeva, V., Aggouridaki, C., Costa, V., & Balogiannis, S. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.020 · Cited by 147
Leyhe, T., Stransky, E., Eschweiler, G. W., Buchkremer, G., & Laske, C. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0764-9 · Cited by 145
Puma, C., Danik, M., Quirion, R., Ramon, F., & Williams, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00469.x · Cited by 143
Marksteiner, J., Kemmler, G., Weiss, E. M., Knaus, G., Ullrich, C., Mechtcheriakov, S., OBERBAUER, H., Auffinger, S., Hinterhoelzl, J., Hinterhuber, H., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.011 · Cited by 143
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 143
Systemic immune system alterations in early stages of Alzheimer's disease
Zhang, R., Miller, R. G., Madison, C. A., Jin, X., Honrada, R., Harris, W., Katz, J., Forshew, D. A., & McGrath, M. S. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.01.002 · Cited by 141
Systemic Inflammation Is Associated with MCI and Its Subtypes: The Sydney Memory and Aging Study
Trollor, J. N., Smith, E., Baune, B. T., Kochan, N. A., Campbell, L. V., Samaras, K., Crawford, J., Brodaty, H., & Sachdev, P. S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000322092 · Cited by 136
Self-citationSchwartz, M., & Shechter, R. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.31 · Cited by 135
Banisadr, G., Gosselin, R., Méchighel, P., Rostène, W. H., Kitabgi, P., & Parsadaniantz, S. M. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20729 · Cited by 135
Johnson, E. A., Dao, T. L., Guignet, M. A., Geddes, C. E., Koemeter-Cox, A., & Kan, R. K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-41 · Cited by 134
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls
Reale, M., Patruno, A., Lutiis, M. A. D., Pesce, M., Felaco, M., Giannantonio, M. D., Nicola, M. D., & Grilli, A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-13 · Cited by 128
Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement
Gould, T. D., & Einat, H. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.05.007 · Cited by 127
CXCL12 increases human neural progenitor cell proliferation through Akt‐1/FOXO3a signaling pathway
Wu, Y., Peng, H., Cui, M., Whitney, N. P., Huang, Y., & Zheng, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06043.x · Cited by 126
Chemokine Action in the Nervous System
Miller, R. J., Rostène, W. H., Apartis, E., Banisadr, G., Biber, K. P. H., Milligan, E. D., White, F. A., & Zhang, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3588-08.2008 · Cited by 126
Rezaie, P., Trillo‐Pazos, G., Everall, I., & Male, D. K. (2001) · Glia · doi:10.1002/glia.1128 · Cited by 123
Kim, T., Lim, H. K., Lee, J. Y., Kim, D., Park, S., Lee, C., & Lee, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.019 · Cited by 121
Subileau, E. A., Rezaie, P., Davies, H. A., Colyer, F. M., Greenwood, J., Male, D. K., & Romero, I. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318197eca7 · Cited by 120
Mattsson, N., Tabatabaei, S., Johansson, P., Hansson, O., Andreasson, U., Månsson, J.-E., Johansson, J.-O., Olsson, B., Wallin, A., Svensson, J., et al. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8147-9 · Cited by 118
CCL5 induces a pro-inflammatory profile in microglia in vitro
Škuljec, J., Sun, H., Pul, R., Bénardais, K., Ragancokova, D., Moharregh-Khiabani, D., Kotsiari, A., Trebst, C., & Stangel, M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.05.001 · Cited by 118
Ji, J. F., He, B. P., Dheen, S. T., & Tay, S. S. W. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.024 · Cited by 116
Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients
Galimberti, D., Schoonenboom, N. S. M., Scarpini, E. A., & Scheltens, P. (2003) · Annals of Neurology · doi:10.1002/ana.10531 · Cited by 116
Weeraratna, A. T., Kalehua, A. N., DeLeon, I., Bertak, D., Maher, G., Wade, M. S., Lustig, A., Becker, K. G., Wood, W. W., Walker, D. G., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.028 · Cited by 116
Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype
Dennison, U., McKernan, D., Cryan, J., & Dinan, T. (2012) · Psychological Medicine · doi:10.1017/s0033291712000074 · Cited by 114
Erbağcı, A. B., Herken, H., Köylüoğlu, O., Yılmaz, N., & Tarakçıoğlu, M. (2001) · Mediators of Inflammation · doi:10.1080/09629350123895 · Cited by 113
Chemokines in bipolar disorder: Trait or state?
Barbosa, I. G., Rocha, N. P., Bauer, M. E., de Miranda, A. S., Huguet, R. B., Reis, H. J., Zunszain, P. A., Horowitz, M. A., Pariante, C. M., & Teixeira, A. L. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0327-6 · Cited by 112
Peripheral Chemokine Receptors, Their Ligands, Cytokines and Alzheimer's Disease
Reale, M., Iarlori, C., Feliciani, C., & Gambi, D. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14203 · Cited by 109
Animal Models of Schizophrenia
Young, J. W., Zhou, X., & Geyer, M. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_62 · Cited by 107
Isung, J., Aeinehband, S., Mobarrez, F., Mårtensson, B., Nordström, P., Åsberg, M., Piehl, F., & Jokinen, J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.123 · Cited by 106
Chemokines and chemokine receptors: New actors in neuroendocrine regulations
Rostène, W. H., Guyon, A., Kular, L., Godefroy, D., Barbieri, F., Bajetto, A., Banisadr, G., Callewaere, C., Conductier, G., Rovère, C., et al. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.07.001 · Cited by 104
Serum chemokine levels in major depressive disorder
Lehto, S. M., Niskanen, L., Herzig, K.-H., Tolmunen, T., Huotari, A., Viinamäki, H., Koivumaa-Honkanen, H., Honkalampi, K., Ruotsalainen, H., & Hintikka, J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.007 · Cited by 100
O’Brien, S. M., Scully, P., & Dinan, T. G. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.014 · Cited by 100
MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels
Fenoglio, C., Galimberti, D., Lovati, C., Guidi, I., Gatti, A., Fogliarino, S., Tiriticco, M., Mariani, C. B., Forloni, G., Pettenati, C., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.008 · Cited by 94
Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide
Isung, J., Mobarrez, F., Nordström, P., Åsberg, M., & Jokinen, J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.624549 · Cited by 94
Peripheral Chemokine Levels in Women with Recurrent Major Depression with Suicidal Ideation
Grassi-Oliveira, R., Brieztke, E., Teixeira, A., Pezzi, J. C., Zanini, M., Lopes, R. P., & Bauer, M. E. (2012) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462012000100013 · Cited by 91 · cited 1×
“ne study found that levels of the chemokines CCL2 and CCL5 ere reduced, and CCL11 increased in the serum of patients with epression and suicidal ideation as compared to those without uicidal ideation (Grassi-Oliveira et al., 2012).”
BackgroundChemokines direct neural progenitor cell migration following striatal cell loss
Gordon, R. J., McGregor, A. L., & Connor, B. J. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.03.001 · Cited by 90
CSF biomarkers in suicide attempters – a principal component analysis
Lindqvist, D., Janelidze, S., Erhardt, S., Träskman‐Bendz, L., Engström, G., & Brundin, L. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01655.x · Cited by 86 · cited 1×
“An attempt to correlate DSM-III defined depression with cerebrospinal fluid (CSF) CXCL8 also failed to demonstrate any significant association in a middle aged (mean age 38) sample (Lindqvist et al., 2011).”
Müller, N., Myint, A.-M., & Schwarz, M. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00003-9 · Cited by 86
Pellicanò, M., Bulati, M., Buffa, S., Barbagallo, M., Di Prima, A., Misiano, G., Picone, P., Di Carlo, M., Nuzzo, D., Candore, G., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091714 · Cited by 86
Eltayeb, S., Berg, A., Lassmann, H., Wallström, E., Nilsson, M., Olsson, T. P., Ericsson‐Dahlstrand, A., & Sunnemark, D. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-14 · Cited by 86
A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress
Razzoli, M., Domenici, E., Carboni, L., Rantamäki, T., Lindholm, J., Ċastrén, E., & Arban, R. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00681.x · Cited by 85
Chemokines in CSF of Alzheimer's disease patients
Corrêa, J. D., Starling, D. S. V., Teixeira, A. L., Caramelli, P., & Silva, T. A. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000400009 · Cited by 85
Increased serum levels of CCL11/eotaxin in schizophrenia
Teixeira, A. L., Reis, H. J., Nicolato, R., Brito-Melo, G., Corrêa, H., Teixeira, M. M., & Romano‐Silva, M. A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.11.019 · Cited by 84
Lymphoid chemokines in the CNS
Lalor, S. J., & Segal, B. M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.017 · Cited by 83
Anti-inflammatory signaling in schizophrenia
Meyer, U. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.014 · Cited by 82
Moderators of the relationship between depression and cardiovascular disorders: a systematic review
Baune, B. T., Stuart, M. J., Gilmour, A., Wersching, H., Arolt, V., & Berger, K. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.05.013 · Cited by 80
Self-citationDevelopmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem
Meng, S. Z., Oka, A., & Takashima, S. (1999) · Brain and Development · doi:10.1016/s0387-7604(98)00065-5 · Cited by 80
Choi, C., Jeong, J.-H., Jang, J. S., Choi, K., Lee, J., Kwon, J., Choi, K., Lee, J.-S., & Kang, S. W. (2008) · Journal of Clinical Neurology · doi:10.3988/jcn.2008.4.2.84 · Cited by 80
Louboutin, J., & Strayer, D. S. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660173 · Cited by 79
Neurodevelopmental Animal Models of Schizophrenia: Role in Novel Drug Discovery and Development
Wilson, C., & Terry, A. V. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.2.4 · Cited by 79
Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain
Girotti, M., Donegan, J. J., & Morilak, D. A. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.008 · Cited by 76
Depressive syndromes in neurological disorders
Hellmann‐Regen, J., Piber, D., Hinkelmann, K., Gold, S. M., Heesen, C., Spitzer, C., Endres, M., & Otte, C. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0448-6 · Cited by 73
In vitro immunoregulatory effects of lithium in healthy volunteers
Maes, M. H. J., Song, C. W., Lin, A.-H., Pioli, R., Kenis, G., Kubera, M., & Bosmans, E. (1999) · Psychopharmacology · doi:10.1007/s002130050965 · Cited by 72
Heinisch, S., & Kirby, L. G. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.022 · Cited by 72
Kamińska, T., Wysocka, A., Marmurowska-Michałowska, H., Dubas-Ślemp, H., & Kandefer‐Szerszeń, M. (2001) · PubMed · Cited by 72
Immune and Neuroimmune Alterations in Mood Disorders and Schizophrenia
Drexhage, R. C., Weigelt, K., van Beveren, N., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2011) · International Review of Neurobiology · doi:10.1016/b978-0-12-387718-5.00007-9 · Cited by 71
Huerta, C., Álvarez, V., Mata, I. F., Coto, E., Ribacoba, R., Martínez, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Lahoz, C. H., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.08.016 · Cited by 71
Identification of peripheral inflammatory markers between normal control and Alzheimer's disease
Kim, S.-M., Song, J., Kim, S., Han, C., Park, M. H., Koh, Y., Jo, S. A., & Kim, Y.-Y. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-51 · Cited by 70
Functional expression of CCR2 by human fetal astrocytes
Andjelkovic, A. V., Song, L., Dzenko, K. A., Cong, H., & Pachter, J. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10372 · Cited by 70
Altered Chemokine Levels in the Cerebrospinal Fluid and Plasma of Suicide Attempters
Janelidze, S., Ventorp, F., Erhardt, S., Hansson, O., Minthon, L., Flax, J., Samuelsson, M., Traskman-Bendz, L., & Brundin, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.010 · Cited by 69
Passos, G. F., Figueiredo, C. P., Prediger, R. D., Pandolfo, P., Duarte, F. S., Medeiros, R., & Calixto, J. Β. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081113 · Cited by 69
Heinisch, S., & Kirby, L. G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.075 · Cited by 63
Laske, C., Stellos, K., Eschweiler, G. W., Leyhe, T., & Gawaz, M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15107 · Cited by 62
Maes, M. H. J. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9326-6 · Cited by 59
CCR1 is an early and specific marker of Alzheimer's disease
Halks‐Miller, M., Schroeder, M. L., Haroutunian, V. H., Moenning, U., Rossi, M. R., Achim, C. L., Purohit, D. P., Mahmoudi, M., & Horuk, R. (2003) · Annals of Neurology · doi:10.1002/ana.10733 · Cited by 58
Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment
Lee, K. S., Chung, J. H., Lee, K. H., Shin, M., Oh, B. H., & Hong, C. H. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.09.004 · Cited by 57
Pharmacological treatment for memory disorder in multiple sclerosis
He, D., Zhang, Y., Dong, S., Wang, D., Gao, X., & Zhou, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876.pub3 · Cited by 56
Pola, R., Flex, A., Gaetani, E., Proia, A. S., Papaleo, P., Giorgio, A. D., Straface, G., Pecorini, G., Serricchio, M., & Pola, P. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.05.001 · Cited by 56
Exercise-induced release of cytokines in patients with major depressive disorder
Hallberg, L., Janelidze, S., Engström, G., Wisén, A. G. M., Westrin, Å., & Brundin, L. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.133 · Cited by 56
Association Between the CCR5 32-bp Deletion Allele and Late Onset of Schizophrenia
Rasmussen, H. B., Timm, S., Wang, A. G., Søeby, K., Lublin, H., Fenger, M., Hemmingsen, R., & Werge, T. M. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.507 · Cited by 55
Campbell, S. J., Meier, U., Mardiguian, S., Jiang, Y., Littleton, E. T., Bristow, A., Relton, J. K., Connor, T. J., & Anthony, D. C. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.01.011 · Cited by 52
Weiss, N., Deboux, C., Chaverot, N., Miller, F., Evercooren, A. B., Couraud, P., & Cazaubon, S. M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.009 · Cited by 48
Danik, M., Puma, C., Quirion, R., & Williams, S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10744 · Cited by 48
Iarlori, C., Gambi, D., Gambi, F., Lucci, I., Feliciani, C., Salvatore, M., & Reale, M. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.007 · Cited by 48
Liu, J. X., Cao, X., Tang, Y. C., Liu, Y., & Tang, F. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04272.x · Cited by 47
Involvement of fractalkine and macrophage inflammatory protein‐1 alpha in moderate‐severe depression
Merendino, R. A., Di Pasquale, G., De Luca, F., Di Pasquale, L., Ferlazzo, E., Martino, G., Palumbo, M. C., Morabito, F., & Gangemi, S. (2004) · Mediators of Inflammation · doi:10.1080/09511920410001713484 · Cited by 47
BIOMARKERS OF NEUROLOGICAL AND PSYCHIATRIC DISEASE
Drexhage, R. C., Weigelt, K., van Beveren, N. J. M., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2011) · Cited by 47
MCP‐1 gene (SCYA2) and schizophrenia: A case‐control association study
Mundo, E., Altamura, A. C., Vismara, S., Zanardini, R., Bignotti, S., Randazzo, R., Montresor, C., & Gennarelli, M. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30100 · Cited by 46
Chronic Variable Stress Alters Inflammatory and Cholinergic Parameters in Hippocampus of Rats
Tagliari, B., Tagliari, A. P., Schmitz, F., da Cunha, A. A., Dalmaz, C., & Wyse, A. T. S. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0367-0 · Cited by 46
RANTES‐mediated control of excitatory amino acid release in mouse spinal cord
Prisco, S. D., Summa, M., Chellakudam, V., Rossi, P. I. A., & Pittaluga, A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07720.x · Cited by 44
van Zuiden, M., Heijnen, C. J., van de Schoot, R., Amarouchi, K., Maas, M., Vermetten, E. H. G. J. M., Geuze, E., & Kavelaars, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029142 · Cited by 44
Zhang, X. Y., Cao, L. Y., Song, C., Wu, G. Y., Chen, D. C., Qi, L. Y., Wang, F., Xiu, M. H., Chen, S., Zhang, Y., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1295-4 · Cited by 43
The MCP-1 Gene (SCYA2) and Mood Disorders: Preliminary Results of a Case-Control Association Study
Altamura, A. C., Mundo, E., Cattaneo, E., Pozzoli, S. M., Dell’Osso, B. M., Gennarelli, M., Vergani, C., Trabattoni, D., Arosio, B., & Clerici, M. (2009) · NeuroImmunoModulation · doi:10.1159/000258696 · Cited by 42
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091077 · Cited by 40
Yao, Y., Schröder, J., & Karlsson, H. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.011 · Cited by 40
Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples
Kester, M. I., van der Flier, W. M., Visser, A., Blankenstein, M. A., Scheltens, P., & Oudejans, C. B. M. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.731 · Cited by 39
CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease
Galimberti, D., Fenoglio, C., Lovati, C., Gatti, A., Guidi, I., Venturelli, E., Cutter, G., Mariani, C. B., Forloni, G., Pettenati, C., et al. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.07.005 · Cited by 37
Blood–Brain Barrier Promotes Differentiation of Human Fetal Neural Precursor Cells
Chintawar, S., Cayrol, R., Antel, J. P., Pandolfo, M., & Prat, A. (2009) · Stem Cells · doi:10.1002/stem.25 · Cited by 36
Pae, C., Yu, H.-S., Kim, T., Lee, C., Lee, S.-J., Jun, T., Lee, C., Serretti, A., & Paik, I. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.004 · Cited by 35
Leukocyte CCR2 Expression Is Associated with Mini-Mental State Examination Score in Older Adults
Harries, L. W., Bradley-Smith, R. M., Llewellyn, D. J., Pilling, L. C., Fellows, A. D., Henley, W., Hernandez, D. G., Guralnik, J. M., Bandinelli, S., Singleton, A., et al. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1302 · Cited by 34
Balistreri, C. R., Grimaldi, M. P., Vasto, S., Listì, F., Chiappelli, M., Licastro, F., Lio, D., Caruso, C., & Candore, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.012 · Cited by 32
Prolonged increase in rat hippocampal chemokine signalling after status epilepticus
Kan, A. A., van der Hel, W. S., Kolk, S. M., Bos, I. W. M., Verlinde, S. A. M. W., van Nieuwenhuizen, O., & Graan, P. N. E. D. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.01.012 · Cited by 32
Hochstrasser, T., Marksteiner, J., Defrancesco, M., Deisenhammer, E. A., Kemmler, G., & Humpel, C. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000330468 · Cited by 31
Licinio, J. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.3 · Cited by 31
Conceptual Challenges of a Tentative Model of Stress-Induced Depression
Baune, B. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004266 · Cited by 31
Self-citationKelland, E. E., Gilmore, W., Weiner, L. P., & Lund, B. T. (2011) · Glia · doi:10.1002/glia.21230 · Cited by 31
DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders
Kamiya, A., Sedlak, T. W., & Pletnikov, M. V. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00025 · Cited by 30
The chemokine receptor CCR5-Δ32 gene mutation is not protective against Alzheimer’s disease
Combarros, O., Infante, J., Llorca, J., Peña, N., Fernández‐Viadero, C., & Berciano, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.058 · Cited by 30
Prisco, S. D., Merega, E., Milanese, M., Summa, M., Casazza, S., Raffaghello, L., Pistoia, V., Uccelli, A., & Pittaluga, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.037 · Cited by 29
Cited by
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449
Black, C., & Miller, B. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.014 · Cited by 366
Jones, K. L., Croen, L. A., Yoshida, C. K., Heuer, L., Hansen, R., Zerbo, O., DeLorenze, G. N., Kharrazi, M., Yolken, R., Ashwood, P., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.77 · Cited by 260
Gut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
Metadata
- Authors
- Stuart, M. J., & Baune, B. T.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 42
- Pages
- 93-115
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2069809946
- Cited by
- 259
- References
- 221
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.